EJNMMI Res. 2015 Dec;5(1):118. doi: 10.1186/s13550-015-0118-y. Epub 2015 Jul 16.
Clinical value of measurement of pulmonary radioaerosol mucociliary clearance in the work up of primary ciliary dyskinesia.
EJNMMI research
Mathias Munkholm, Kim Gjerum Nielsen, Jann Mortensen
Affiliations
Affiliations
- Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen University Hospital, DK-2100, Copenhagen Ø, Denmark.
PMID: 26179226
PMCID: PMC4503709 DOI: 10.1186/s13550-015-0118-y
Abstract
BACKGROUND: We aimed to evaluate and define the general clinical applicability and impact of pulmonary radioaerosol mucociliary clearance (PRMC) on the work up of patients suspected of having primary ciliary dyskinesia (PCD). In addition, we wanted to evaluate the accuracy of the reference values used in the PRMC test.
METHODS: Measurement of PRMC after inhalation of (99m)Tc-albumin colloid aerosol was carried out on 239 patients (4-75 years of age) during a 9-year period. All were referred to the nuclear medicine department because of clinical suspicion of PCD. The results were compared primarily to results from nasal ciliary function testing, to electron microscopic (EM) examination of the ultrastructure of the cilia, and to the final clinical diagnosis.
RESULTS: Of the 239 patients, 27 ended up with a final clinical diagnosis of definitive PCD. No patients with a PRMC test that was normal or otherwise not consistent with PCD ended up with PCD as final clinical diagnosis (though a minority of patients in this group ended up unresolved in regard to PCD). Forty percent of patients with an abnormal PRMC test ended up with PCD as final clinical diagnosis. Furthermore, the PRMC test had a high rate of conclusive results (90 %). Children <14 years of age with normal PRMC measurements showed significantly faster lung clearance than adults with similarly normal PRMC measurements.
CONCLUSIONS: To this date, PRMC is the only test providing evaluation of the mucociliary clearance of the entire lung. Its greatest strength is its ability to reject a suspected PCD diagnosis with great certainty. In our material, this accounted for 2/3 of referred patients. In addition, the test has a high rate of conclusive results. According to our analyses, reference equations on children would benefit from updated data.
References
- Eur Respir J. 2011 Mar;37(3):566-71 - PubMed
- Hum Mutat. 2008 Feb;29(2):289-98 - PubMed
- Am J Hum Genet. 2012 Oct 5;91(4):672-84 - PubMed
- J Pathol. 2004 Nov;204(4):470-7 - PubMed
- Arch Dis Child. 1996 Oct;75(4):319-22 - PubMed
- Eur J Respir Dis Suppl. 1983;127:57-63 - PubMed
- J Nucl Med. 1987 Feb;28(2):161-7 - PubMed
- Proc Am Thorac Soc. 2011 Sep;8(5):434-7 - PubMed
- Paediatr Respir Rev. 2009 Jun;10(2):51-4 - PubMed
- Clin Physiol Funct Imaging. 2014 May;34(3):171-7 - PubMed
- Dan Med Bull. 2010 Aug;57(8):B4174 - PubMed
- Am J Respir Crit Care Med. 2004 Feb 15;169(4):459-67 - PubMed
- Am J Respir Crit Care Med. 2000 Dec;162(6):2218-20 - PubMed
- Pediatr Allergy Immunol. 2001 Oct;12(5):274-82 - PubMed
- Pediatr Allergy Immunol. 2010 Dec;21(8):1139-45 - PubMed
- Eur Respir J. 2009 Dec;34(6):1264-76 - PubMed
- Angle Orthod. 2012 Nov;82(6):985-92 - PubMed
- Arch Dis Child. 2007 Dec;92(12):1136-40 - PubMed
- Clin Exp Allergy. 2002 May;32(5):698-701 - PubMed
- Eur J Pediatr. 1998 May;157(5):422-6 - PubMed
- Respir Med. 2008 Apr;102(4):541-7 - PubMed
- Eur Respir J. 2011 Mar;37(3):559-65 - PubMed
- Clin Physiol. 1991 Sep;11(5):439-50 - PubMed
- Arch Dis Child. 2014 Sep;99(9):850-6 - PubMed
- Chest. 2010 Dec;138(6):1441-7 - PubMed
- Methods Cell Biol. 2009;91:123-33 - PubMed
- N Engl J Med. 1990 Dec 13;323(24):1681-4 - PubMed
- Eur Respir J. 1997 Oct;10(10):2376-9 - PubMed
- Dan Med Bull. 1998 Apr;45(2):195-209 - PubMed
- Chest. 2007 Sep;132(3):966-76 - PubMed
- Eur J Respir Dis Suppl. 1983;127:41-56 - PubMed
- Eur J Nucl Med. 1994 Sep;21(9):953-61 - PubMed
- Eur Respir J. 2014 Aug;44(2):533-5 - PubMed
Publication Types